Dr. Arsani William, MD, MBA

Dr. William serves as the firm’s Chief Investment Office & Managing Partner, overseeing portfolio construction, risk management, and strategy across public and private markets.

Prior to founding Logos, Dr. William was an investment professional at Farallon Capital Management, where he helped drive the expansion of the firm’s biopharma portfolio and investment framework.

He previously trained as a physician and completed his MD at Harvard Medical School as a Gerald S. Foster Scholar, his MBA at Stanford Graduate School of Business, and his BS with Honors in Biology at Stanford University.

Dr. William serves on multiple private biotechnology boards and is an active member of the Bay Area biopharma community.